Clinical trial
Cannabinoids in Bipolar Affective Disorder
NCT00397605 · University of British Columbia, Other · Withdrawn
Key facts
| NCT number | NCT00397605 |
|---|---|
| Title | Cannabinoids in Bipolar Affective Disorder |
| Official title | Cannabinoids in Bipolar Affective Disorder: A Controlled Pilot Study |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Vancouver General Hospital |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Bipolar Affective Disorder |
| Intervention type | Drug |
| Interventions | Synthetic cannabinoids (1:1 ratio of THC % CBD) |
| Enrollment | 0 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Nov 9, 2006 |
| Last update posted | Sep 18, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: